| Sample | Title | Value | Rank |
|---|
| GSM780707 | Untreated after 4 days (C1_1) | 46.0957 | 32 |
| GSM780708 | Untreated after 4 days (C2_1) | 44.1646 | 23 |
| GSM780709 | Untreated after 4 days (C3_1) | 43.7058 | 21 |
| GSM780719 | Untreated after 4 days (C1_2) | 43.6345 | 20 |
| GSM780720 | Untreated after 4 days (C2_2) | 47.3745 | 38 |
| GSM780721 | Untreated after 4 days (C3_2) | 41.8665 | 13 |
| GSM780710 | Trastuzumab treated after 4 days (T1_1) | 49.0773 | 45 |
| GSM780711 | Trastuzumab treated after 4 days (T2_1) | 46.6274 | 35 |
| GSM780712 | Trastuzumab treated after 4 days (T3_1) | 45.5497 | 30 |
| GSM780722 | Trastuzumab treated after 4 days (T1_2) | 45.2561 | 28 |
| GSM780723 | Trastuzumab treated after 4 days (T2_2) | 42.5008 | 15 |
| GSM780724 | Trastuzumab treated after 4 days (T3_2) | 46.4948 | 34 |
| GSM780713 | Pertuzumab treated after 4 days (P1_1) | 45.9094 | 32 |
| GSM780714 | Pertuzumab treated after 4 days (P2_1) | 46.6184 | 35 |
| GSM780715 | Pertuzumab treated after 4 days (P3_1) | 50.6005 | 50 |
| GSM780725 | Pertuzumab treated after 4 days (P1_2) | 42.9278 | 17 |
| GSM780726 | Pertuzumab treated after 4 days (P2_2) | 46.5295 | 35 |
| GSM780727 | Pertuzumab treated after 4 days (P3_2) | 47.5514 | 39 |
| GSM780716 | Trastuzumab and Pertuzumab treated after 4 days (TP1_1) | 42.162 | 14 |
| GSM780717 | Trastuzumab and Pertuzumab treated after 4 days (TP2_1) | 40.7711 | 9 |
| GSM780718 | Trastuzumab and Pertuzumab treated after 4 days (TP3_1) | 47.0872 | 37 |
| GSM780728 | Trastuzumab and Pertuzumab treated after 4 days (TP1_2) | 47.4728 | 39 |
| GSM780729 | Trastuzumab and Pertuzumab treated after 4 days (TP2_2) | 45.4951 | 30 |